Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 4,425 $ 3,930
Premium and related receivables 3,901 3,098
Short-term investments 586 505
Other current assets 736 832
Total current assets 9,648 8,365
Long-term investments 4,816 4,545
Restricted deposits 137 138
Property, software and equipment, net 912 797
Goodwill 4,712 4,712
Intangible assets, net 1,466 1,545
Other long-term assets 149 95
Total assets 21,840 20,197
Current liabilities:    
Medical claims liability 4,170 3,929
Accounts payable and accrued expenses 4,238 4,377
Unearned revenue 554 313
Current portion of long-term debt 4 4
Total current liabilities 8,966 8,623
Long-term debt 4,716 4,651
Other long-term liabilities 1,630 869
Total liabilities 15,312 14,143
Commitments and contingencies
Redeemable noncontrolling interests 136 145
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2017 and December 31, 2016 0 0
Common stock, $0.001 par value; authorized 400,000 shares; 178,900 issued and 172,467 outstanding at June 30, 2017, and 178,134 issued and 171,919 outstanding at December 31, 2016 0 0
Additional paid-in capital 4,258 4,190
Accumulated other comprehensive earnings (loss) 1 (36)
Retained earnings 2,313 1,920
Treasury stock, at cost (6,433 and 6,215 shares, respectively) (194) (179)
Total Centene stockholders’ equity 6,378 5,895
Noncontrolling interest 14 14
Total stockholders’ equity 6,392 5,909
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 21,840 $ 20,197